The Form 4 filing, an SEC report used to disclose insider stock trades, was filed on November 19, 2026. It covers sales from November 17 through November 18. George Kurtz, who reported the sales, serves as CrowdStrike Holdings' president and CEO.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-17 |
| Date of Latest Transaction | 2026-11-18 |
| Buy/Sell | sell |
| Transaction Count | 28 |
| Shares Transacted | 20,000 |
| Price | $225.38 |
| Total Transaction Value | $4,507,504.01 |
| Insider | |
| Ticker Symbol | CRWD |
| Company | CrowdStrike Holdings, Inc. |
| Insider Name | Kurtz George |
| Insider Title | PRESIDENT AND CEO |
| Sector - Industry | Technology - Software - Infrastructure |
| Holdings | |
| Total Shares Owned After Transaction | 7,183,109 |
| Position Size Change | 0.28% |
| Filing | |
| Filing Date | 2026-11-19 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of CrowdStrike Holdings (CRWD) shares, marked with transaction code S. George Kurtz reported 28 transactions in one filing.
What was the average price of the transaction?
The average sale price was $225.38 per share, rounded to the nearest cent. That average covers the reported sales; separate prices for each trade are not available here.
How did this transaction affect the insider's holdings?
After selling 20,000 shares, George Kurtz reported owning 7,183,109 shares. The sale represented about 0.28% of his shares owned before the sale. These figures put his reported holdings before the sales at 7,203,109 shares.
What's the total transaction value?
The total transaction value was $4,507,504.01 for the 20,000 shares sold. This amount covers all 28 transactions reported in the filing.
Are there any special circumstances around this transaction?
The transaction information notes a reference to a Rule 10b5-1 trading plan. These plans set trading instructions in advance. The reference may apply to the filing as a whole. Footnote text is not available here, so it is unclear which sales it covers. The plan's start date, schedule and other terms are unknown.
For research purposes only; not investment advice.